The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Laparscopic Inguinal Hernia Repair - Does the Choice of Self-fixated Mesh Matter?

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT05091853
Recruitment Status : Active, not recruiting
First Posted : October 25, 2021
Last Update Posted : March 13, 2024
Sponsor:
Information provided by (Responsible Party):
Anna-Maria Thölix, Helsinki University Central Hospital

Tracking Information
First Submitted Date  ICMJE October 13, 2021
First Posted Date  ICMJE October 25, 2021
Last Update Posted Date March 13, 2024
Actual Study Start Date  ICMJE May 9, 2021
Actual Primary Completion Date July 31, 2023   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures  ICMJE
 (submitted: October 13, 2021)
Pain during the first post-operative week [ Time Frame: 1 year ]
The degree of pain (VAS score) and the use of pain medication during the first postoperative week
Original Primary Outcome Measures  ICMJE Same as current
Change History
Current Secondary Outcome Measures  ICMJE Not Provided
Original Secondary Outcome Measures  ICMJE Not Provided
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title  ICMJE Laparscopic Inguinal Hernia Repair - Does the Choice of Self-fixated Mesh Matter?
Official Title  ICMJE Laparscopic Inguinal Hernia Repair - Does the Choice of Self-fixated Mesh Matter?
Brief Summary Self-fixed mesh and postoperative pain after laparoscopic inguinal hernia surgery, a randomized clinical trial
Detailed Description Pain after inguinal hernia surgery is a major problem for the patient and results in lower quality of life. In this randomized clinical trial we examine if the choice of self-fixed mesh affects post-operative inguinal pain in laparoscopic hernia surgery. 164 patients are randomized and followed up for 1 year.
Study Type  ICMJE Interventional
Study Phase  ICMJE Not Applicable
Study Design  ICMJE Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Care Provider)
Primary Purpose: Treatment
Condition  ICMJE
  • Inguinal Hernia
  • Surgery
Intervention  ICMJE Device: Adhesix mesh
2 meshes are used; the self-gripping Progrip mesh and the self-adhesive Adhesix mesh
Other Name: Progrip mesh
Study Arms  ICMJE
  • Active Comparator: Self-adhesive mesh
    Intervention: Device: Adhesix mesh
  • Active Comparator: Self-gripping mesh
    Intervention: Device: Adhesix mesh
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status  ICMJE Active, not recruiting
Estimated Enrollment  ICMJE
 (submitted: October 13, 2021)
164
Original Estimated Enrollment  ICMJE Same as current
Estimated Study Completion Date  ICMJE June 30, 2024
Actual Primary Completion Date July 31, 2023   (Final data collection date for primary outcome measure)
Eligibility Criteria  ICMJE

Inclusion Criteria:

  • patients with a clinical inguinal hernia, who are operated with laparoscopic surgery in day case surgery

Exclusion Criteria:

  • scrotal or incarcerated hernia
  • previous laparotomy
  • ASA >3
  • BMI <18 or >35
  • Liver cirrhosis
  • No hernia in clinical examination
Sex/Gender  ICMJE
Sexes Eligible for Study: All
Ages  ICMJE 18 Years to 90 Years   (Adult, Older Adult)
Accepts Healthy Volunteers  ICMJE No
Contacts  ICMJE Contact information is only displayed when the study is recruiting subjects
Listed Location Countries  ICMJE Finland
Removed Location Countries  
 
Administrative Information
NCT Number  ICMJE NCT05091853
Other Study ID Numbers  ICMJE HUS/3413/2020
Has Data Monitoring Committee No
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement  ICMJE
Plan to Share IPD: No
Current Responsible Party Anna-Maria Thölix, Helsinki University Central Hospital
Original Responsible Party Same as current
Current Study Sponsor  ICMJE Helsinki University Central Hospital
Original Study Sponsor  ICMJE Same as current
Collaborators  ICMJE Not Provided
Investigators  ICMJE Not Provided
PRS Account Helsinki University Central Hospital
Verification Date March 2024

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP